TY - JOUR
T1 - Primary Thrombophilia in México XI
T2 - Activated Protein C Resistance Phenotypes are Multifactorial
AU - Vallejo-Villalobos, Ma Fernanda
AU - León-Peña, Andrés
AU - León-González, Mónica
AU - Núñez-Cortés, Ana Karen
AU - Olivares-Gazca, Juan Carlos
AU - Valdés-Tapia, Patricia
AU - Garcés-Eisele, Javier
AU - Ruiz-Argüelles, Alejandro
AU - Ruiz-Argüelles, Guillermo J.
N1 - Publisher Copyright:
© 2016, Indian Society of Haematology & Transfusion Medicine.
PY - 2017/9/1
Y1 - 2017/9/1
N2 - Activated protein C resistance (aPCR) phenotypes represent around 20% of the laboratory findings in Mexican Mestizos having suffered thrombosis and displaying clinical markers of thrombophilia. In a single institution for a 276-month period, 96 Mexican mestizos with a history of thrombosis and clinical markers of a primary thrombophilic state were prospectively studied to identify a thrombophilic condition. An abnormal aPCR phenotype was identified in 18 individuals. Evaluation of those with an abnormal aPCR phenotype, identified that 44% had factor V Leiden mutation, 22% increased levels of factor VIII, 16% anti-phospholipid antibodies and 6% a lupus anticoagulant. In the remaining 22%, the use of direct oral anticoagulants (DOACs) in the past period of 12–24 h was recorded. We found significant associations between abnormal aPCR phenotype and the factor V Leiden mutation (p = 0022), between abnormal aPCR phenotype and the use of DOACs (p = 0.006) and between antiphospholipid antibodies and lupus anticoagulant (p < 0.0001). These data are consonant with those observed in other populations and further identify that consideration be given to identifying whether individuals are being treated with the novel DOACs when conducting laboratory studies oriented to identify the etiology of thrombosis.
AB - Activated protein C resistance (aPCR) phenotypes represent around 20% of the laboratory findings in Mexican Mestizos having suffered thrombosis and displaying clinical markers of thrombophilia. In a single institution for a 276-month period, 96 Mexican mestizos with a history of thrombosis and clinical markers of a primary thrombophilic state were prospectively studied to identify a thrombophilic condition. An abnormal aPCR phenotype was identified in 18 individuals. Evaluation of those with an abnormal aPCR phenotype, identified that 44% had factor V Leiden mutation, 22% increased levels of factor VIII, 16% anti-phospholipid antibodies and 6% a lupus anticoagulant. In the remaining 22%, the use of direct oral anticoagulants (DOACs) in the past period of 12–24 h was recorded. We found significant associations between abnormal aPCR phenotype and the factor V Leiden mutation (p = 0022), between abnormal aPCR phenotype and the use of DOACs (p = 0.006) and between antiphospholipid antibodies and lupus anticoagulant (p < 0.0001). These data are consonant with those observed in other populations and further identify that consideration be given to identifying whether individuals are being treated with the novel DOACs when conducting laboratory studies oriented to identify the etiology of thrombosis.
KW - Protein C
KW - Resistance
KW - Thrombophilia
UR - http://www.scopus.com/inward/record.url?scp=85006484073&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85006484073&partnerID=8YFLogxK
U2 - 10.1007/s12288-016-0767-7
DO - 10.1007/s12288-016-0767-7
M3 - Article
C2 - 28824240
AN - SCOPUS:85006484073
SN - 0971-4502
VL - 33
SP - 375
EP - 379
JO - Indian Journal of Hematology and Blood Transfusion
JF - Indian Journal of Hematology and Blood Transfusion
IS - 3
ER -